Sex differences exist in the site specific incidences of colorectal cancer. The increased incidence of colonic cancer in women with breast cancer and the protective effect of increasing parity suggest a role for sex hormones. To explore the molecular basis, the expression of messenger RNA for oestrogen and progesterone receptors in the large bowel has been studied. 
Cancer of the colon is more common in women up to 55 years of age but thereafter is more common in men; rectal cancer occurs with almost equal frequency in both sexes up to 45 years of age, but becomes almost twice as common in men after the age of 65 years. ' Table II ). Cancers of the sigmoid colon and at the rectosigmoid junction were analysed together in the 'sigmoid' group. All cancers were adenocarcinomata. There were six polyps less than 1 cm (two women), and four in the range 1-2 cm, all were tubulovillous on histological examination and were from men. All polyps originated from either the sigmoid colon or the rectum. units. Positive controls of normal breast and normal endometrium had oestrogen and progesterone receptor values in the range 0 5-3-0 units and 1 0-5 0 units respectively. No nonspecific hybridisation was seen to ribosomal RNA. mRNA for both oestrogen and progesterone receptor was detected in all large bowel specimens in amounts comparable with that seen in breast and endometrial tissues. Oestrogen receptor enzyme immunoassay results were available for 16 pairs ofnormal and cancer tissues and ranged between 1-2-7A4 fmol/mg of total protein. This amount is comparable with that found in normal breast tissue of between 2-10 fmol/mg depending on the phase of the menstrual cycle,26 but is much less than the 300 fmol/mg seen in the endometrium.27 Table II shows that there were no statistically significant differences in receptor expression between large bowel specimens from men and women (Mann-Whitney test). The differences in oestrogen and progesterone receptor mRNA concentrations between Dukes's stage C and D cancers and Dukes's A and B cancers were not statistically significant, and were not supported by a similar difference in oestrogen receptor protein by enzyme immunoassay. 
